These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 9733874

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. MHC class II-restricted presentation of endogenously synthesized antigen: Epstein-Barr virus transformed B cell lines can present the viral glycoprotein gp340 by two distinct pathways.
    Lee SP, Wallace LE, Mackett M, Arrand JR, Searle PF, Rowe M, Rickinson AB.
    Int Immunol; 1993 May; 5(5):451-60. PubMed ID: 8391306
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Use of Epstein-Barr virus-transformed, autologous B-lymphoblastoid cells as antigen-presenting cells for establishment and maintenance of dengue virus-specific, human cytotoxic T lymphocyte clones.
    Livingston PG, Kurane I, Ennis FA.
    J Virol Methods; 1997 Aug; 67(1):77-84. PubMed ID: 9274820
    [Abstract] [Full Text] [Related]

  • 5. Presentation of Candida albicans and purified protein derivative soluble antigens by Epstein-Barr virus-transformed human lymphoblastoid B-cell lines.
    Reitnauer PJ, Brown LR, Hank JA, Sondel PM.
    Cell Immunol; 1986 Apr 15; 99(1):196-208. PubMed ID: 3019572
    [Abstract] [Full Text] [Related]

  • 6. The role of tetraspanin CD63 in antigen presentation via MHC class II.
    Petersen SH, Odintsova E, Haigh TA, Rickinson AB, Taylor GS, Berditchevski F.
    Eur J Immunol; 2011 Sep 15; 41(9):2556-61. PubMed ID: 21660937
    [Abstract] [Full Text] [Related]

  • 7. Recognition of endogenously synthesized HLA-DR4 restricted HCV epitopes presented by autologous EBV transformed B-lymphoblastoid cell line.
    Yang M, Zhu F, Sønderstrup G, Eckels DD.
    Vaccine; 2005 Jan 04; 23(7):951-62. PubMed ID: 15603898
    [Abstract] [Full Text] [Related]

  • 8. Differential recognition of tumor-derived and in vitro Epstein-Barr virus-transformed B-cell lines by fetal calf serum-specific T4-positive cytotoxic T-lymphocyte clones.
    Torsteinsdottir S, Masucci MG, Brautbar C, Lenoir G, Klein G, Klein E.
    Cell Immunol; 1986 Apr 01; 98(2):453-66. PubMed ID: 3019570
    [Abstract] [Full Text] [Related]

  • 9. Induction of autologous CD4- and CD8-mediated T-cell responses against acute lymphocytic leukemia cell line using apoptotic tumor cell-loaded dendritic cells.
    Hatakeyama N, Tamura Y, Sahara H, Suzuki N, Suzuki K, Hori T, Mizue N, Torigoe T, Tsutsumi H, Sato N.
    Exp Hematol; 2006 Feb 01; 34(2):197-207. PubMed ID: 16459188
    [Abstract] [Full Text] [Related]

  • 10. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
    Santoli D, Radka SF, Igarashi M, Kreider BL, Ferrone S.
    J Immunol; 1986 Jul 15; 137(2):400-7. PubMed ID: 2941479
    [Abstract] [Full Text] [Related]

  • 11. Reinforcement of cell-mediated immunity driven by tumor-associated Epstein-Barr virus (EBV)-specific T cells during targeted B-cell therapy with rituximab.
    Tischer-Zimmermann S, Bonifacius A, Santamorena MM, Mausberg P, Stoll S, Döring M, Kalinke U, Blasczyk R, Maecker-Kolhoff B, Eiz-Vesper B.
    Front Immunol; 2023 Jul 15; 14():878953. PubMed ID: 37033971
    [Abstract] [Full Text] [Related]

  • 12. Direct killing of Epstein-Barr virus (EBV)-infected B cells by CD4 T cells directed against the EBV lytic protein BHRF1.
    Landais E, Saulquin X, Scotet E, Trautmann L, Peyrat MA, Yates JL, Kwok WW, Bonneville M, Houssaint E.
    Blood; 2004 Feb 15; 103(4):1408-16. PubMed ID: 14563644
    [Abstract] [Full Text] [Related]

  • 13. Hybrid cells formed by fusion of Epstein-Barr virus-associated B-lymphoblastoid cells and either marrow-derived or solid tumour-derived cell lines display different co-stimulatory phenotypes and abilities to activate allogeneic T-cell responses in vitro.
    Cywinski AL, Dunnion DJ, Teobald I, Tucker VC, Browning MJ.
    Tissue Antigens; 2006 Aug 15; 68(2):115-26. PubMed ID: 16866881
    [Abstract] [Full Text] [Related]

  • 14. CD4+ T-cell clones recognizing human lymphoma-associated antigens: generation by in vitro stimulation with autologous Epstein-Barr virus-transformed B cells.
    Long HM, Zuo J, Leese AM, Gudgeon NH, Jia H, Taylor GS, Rickinson AB.
    Blood; 2009 Jul 23; 114(4):807-15. PubMed ID: 19443664
    [Abstract] [Full Text] [Related]

  • 15. Epstein-Barr virus-transformed B-cells as efficient antigen presenting cells to propagate Aspergillus-specific cytotoxic T-lymphocytes.
    Ramadan G.
    Egypt J Immunol; 2008 Jul 23; 15(1):145-57. PubMed ID: 20306679
    [Abstract] [Full Text] [Related]

  • 16. Induction of minor histocompatibility antigen-specific T-helper but not T-cytotoxic response is dependent on the source of antigen-presenting cell.
    van Els CA, Bakker A, van Rood JJ, Goulmy E.
    Hum Immunol; 1990 May 23; 28(1):39-50. PubMed ID: 2160446
    [Abstract] [Full Text] [Related]

  • 17. Differential antigen presentation by heat-treated peripheral blood mononuclear cells and Epstein-Barr virus-transformed lymphoblastoid cell lines (EBV-LCL): heated EBV-LCL present alloantigen and soluble antigen but are deficient in the stimulation of autologous EBV-LCL primed T cells.
    Mandell RB, Hank JA, Chen BP, Robins HI, Sondel PM.
    Hum Immunol; 1987 Jul 23; 19(3):163-77. PubMed ID: 3040644
    [Abstract] [Full Text] [Related]

  • 18. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
    Hauber I, Gulle H, Wolf HM, Maris M, Eggenbauer H, Eibl MM.
    J Exp Med; 1995 Apr 01; 181(4):1411-23. PubMed ID: 7699327
    [Abstract] [Full Text] [Related]

  • 19. Alloantigen presentation by B cells: analysis of the requirement for B-cell activation.
    Wilson JL, Cunningham AC, Kirby JA.
    Immunology; 1995 Nov 01; 86(3):325-30. PubMed ID: 8550066
    [Abstract] [Full Text] [Related]

  • 20. Artificial antigen-presenting cells expressing HLA class II molecules as an effective tool for amplifying human specific memory CD4(+) T cells.
    Garnier A, Hamieh M, Drouet A, Leprince J, Vivien D, Frébourg T, Le Mauff B, Latouche JB, Toutirais O.
    Immunol Cell Biol; 2016 Aug 01; 94(7):662-72. PubMed ID: 26924643
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.